Endothelial progenitor cells for vasculogenesis

Physiology

Volumn 20, Issue 1, 2005, Pages 36-42

  Murasawa, Satoshi ^a   Asahara, Takayuki ^a,b  

^a RIKEN   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TELOMERASE REVERSE TRANSCRIPTASE; VASCULOTROPIN;

ADENOVIRUS VECTOR; ANGIOGENESIS; BLOOD; BONE MARROW CELL; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL TRANSPLANTATION; CELL TYPE; ENDOTHELIUM CELL; ENDOTHELIUM PROGENITOR CELL; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIA; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REVIEW; STEM CELL; TREATMENT OUTCOME; ANIMAL; GENE THERAPY; PHYSIOLOGY; STEM CELL TRANSPLANTATION;

ANIMALS; ENDOTHELIAL CELLS; GENE THERAPY; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 34250336315     PISSN: 15489213     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiol.00033.2004     Document Type: Review

References (46)

1. Anklesaria P, Kase K, Glowacki J, Holland CA, Sakakeeny MA, Wright JA, FitzGerald TJ, Lee CY, and Greenberger JS. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 84: 7681-7685, 1987.
2. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearney M, Magner M, and Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
4. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, and Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972, 1999.
5. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, and Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333: 283-287, 1995.
6. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Kendraprasad H, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, and Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996.
7. -/- mice. Circulation 99: 3188-3198, 1999.
8. Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, and Bowen-Pope DF. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 87: 728-730, 2000.
9. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, and Zeiher AM. HMG-CoA-reductase inhibitors (statins) increase endothelial progenitor cells via the P13 kinase/Akt pathway. J Clin Invest 108: 391-397, 2001.
10. Evans JT, Kelly PF, O'Neill E, and Garcia JV. Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors. Hum Gene Ther 10: 1479-1489, 1999.
11. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hilan KJ, and Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996.
12. Flamme I and Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 116: 435-439, 1992.
13. Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendoubi M, Sidman RL, Wolfe JH, Kim SU, and Snyder EY. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 16: 1033-1039, 1998.
14. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
15. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schunch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK, and Fiedler W. In vivo differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112, 2000.
16. Gunsilius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockha G, Gabl C, Dirnhofer S, Clausen J, and Gastl G. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355: 1688-1691, 2000.
17. Hatzopoulos AK, Folkman J, Vasile E, Eiselen GK, and Rosenberg RD. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125: 1457-1468, 1998.
18. His W. Leoithoblast und angioblast der wirbelthiere. Abhandl K S Ges Wiss Math Phys 22: 171-328, 1900.
19. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, and Asahara T. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732-738, 2002.
20. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, Pieczek A, Iwaguro H, Hayashi SI, Isner JM, and Asahara T. Vascular endothelial growth factor 165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86: 1198-1202, 2000.
21. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, and Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427, 2000.
22. Kalka C, Tehrani H, Laudenberg B, Vale PR, Isner JM, Asahara T, and Symes JF. Mobilization of endothelial progenitor cells following gene therapy with VEGF165 in patients with inoperable coronary disease. Ann Thorac Surg 70: 829-834, 2000.
23. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, and Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637, 2001.
24. Kessinger A and Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77: 211-213, 1991.
25. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkoff D, Wang J, Homma S, Edwards NM, and Itescu S. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436, 2001.
26. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, and Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6: 1004-1010, 2000.
27. Lin Y, Weisdorf DJ, Solovey A, and Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77, 2000.
28. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, and Marsden CD. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247: 574-577, 1990.
29. Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, Walsh K, Isner JM, and Asahara T. HMG-CoA reductase inhibitor mobilizes bone-marrow derived endothelial progenitor cells. J Clin Invest 108: 399-405, 2001.
30. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, and Kolattukudy PE. Contribution of monocytes/macrophages to compensatory neovascularization. The drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 87: 378-384, 2000.
31. Murasawa S, Llevadot J, Silver M, Isner JM, Losordo DW, and Asahara T. Constitutive hTERT expression enhances regenerative properties of endothelial progenitor cells. Circulation 106: 1133-1139, 2002.
32. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, and Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105: 1527-1536, 2000.
33. Pardanaud L, Altman C, Kitos P, and Dieterien-Lievre F. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105: 473-485, 1989.
34. Peichev M, Naiyer AJ, Pereira D, Ahu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, and Moore MAS. Expression of VEGFR-2 and AC133 by human CD34+ cells identifies a population of functional endothelial precursors. Blood 95: 952-958, 2000.
35. Risau W and Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 11: 73-91, 1995.
36. Risau W, Sariola H, Zerwes HG, Sasse J, Ekblom P, Kemler R, and Doetschman T. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development 102: 471-478, 1988.
37. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, and Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 376: 62-66, 1995.
38. Sheridan WP, Begley CG, and Juttener C. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339: 640-644, 1992.
39. Shi Q, Rafii S, Wu MHD, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MAS, Storb RF, and Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367, 1998.
40. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki S, Shimada T, Oike Y, and Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103: 2776-2779, 2001.
41. Shpall EJ, Jones RB, and Bearman SI. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy. J Clin Oncol 12: 28-36, 1994.
42. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, and Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438, 1999.
43. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, and Isner JM. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest 93: 662-670, 1994.
44. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, and Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786, 2002.
45. Vasa M, Fichtischerer S, Adler K, Aicher A, Martin H, Zeiher AM, and Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890, 2001.
46. Weiss M and Orkin SH. In vitro differentiation of murine embryonic stem cells: new approaches to old problems. J Clin Invest 97: 591-595, 1996.